PRADEEP K MANUDHANE
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- CANTON, OH
- NPI
- 1316991599
- Received
- $1,516,409 in 2,312 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 435 | $322,832 |
| 2024 | General payment | 314 | $227,055 |
| 2023 | General payment | 370 | $271,055 |
| 2022 | General payment | 369 | $236,469 |
| 2021 | General payment | 276 | $170,011 |
| 2020 | General payment | 156 | $81,426 |
| 2019 | General payment | 392 | $207,559 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 545 | $1,239,973 |
| Consulting Fee | 37 | $108,230 |
| Travel and Lodging | 660 | $100,084 |
| Food and Beverage | 1,041 | $37,572 |
| Honoraria | 11 | $29,975 |
| Education | 17 | $573 |
| Gift | 1 | $0 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | Vanda Pharmaceuticals Inc. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-19 | Vanda Pharmaceuticals Inc. | $1,680 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-19 | Vanda Pharmaceuticals Inc. | $112 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-19 | Vanda Pharmaceuticals Inc. | $38 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-19 | Vanda Pharmaceuticals Inc. | $33 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-19 | Vanda Pharmaceuticals Inc. | $22 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-18 | ABBVIE INC. | $2,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-18 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-18 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-16 | Teva Pharmaceuticals USA, Inc. | $2,995 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-12-16 | Teva Pharmaceuticals USA, Inc. | $107 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-12-16 | Teva Pharmaceuticals USA, Inc. | $12 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-12-16 | Teva Pharmaceuticals USA, Inc. | $4 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-12-15 | E.R. Squibb & Sons, L.L.C. | $217 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $136 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-15 | E.R. Squibb & Sons, L.L.C. | $114 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $95 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $63 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-15 | E.R. Squibb & Sons, L.L.C. | $22 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-15 | E.R. Squibb & Sons, L.L.C. | $11 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $9 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-09 | ABBVIE INC. | $63 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-09 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-08 | E.R. Squibb & Sons, L.L.C. | $120 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-08 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-12-04 | Vanda Pharmaceuticals Inc. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-04 | Vanda Pharmaceuticals Inc. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-04 | Vanda Pharmaceuticals Inc. | $39 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-02 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-01 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-01 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-01 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $114 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $107 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-26 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-25 | E.R. Squibb & Sons, L.L.C. | $7,015 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $162 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $44 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-25 | Teva Pharmaceuticals USA, Inc. | $12 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-24 | ABBVIE INC. | $1,925 | Consulting Fee | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-24 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $156 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $106 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-18 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-18 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2025 | |
| 2025-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-14 | Vanda Pharmaceuticals Inc. | $2,730 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-14 | Vanda Pharmaceuticals Inc. | $170 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-14 | Vanda Pharmaceuticals Inc. | $39 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-11-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $100 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $196 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | E.R. Squibb & Sons, L.L.C. | $119 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-06 | E.R. Squibb & Sons, L.L.C. | $88 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | E.R. Squibb & Sons, L.L.C. | $10 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-05 | E.R. Squibb & Sons, L.L.C. | $690 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-05 | E.R. Squibb & Sons, L.L.C. | $11 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-03 | Teva Pharmaceuticals USA, Inc. | $11 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $111 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-28 | Alkermes, Inc. | $48 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-10-28 | Axsome Therapeutics, Inc. | $7 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-27 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | Vanda Pharmaceuticals Inc. | $2,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-23 | Vanda Pharmaceuticals Inc. | $94 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-23 | Vanda Pharmaceuticals Inc. | $7 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-22 | Teva Pharmaceuticals USA, Inc. | $529 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-10-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-21 | Teva Pharmaceuticals USA, Inc. | $12 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-20 | Vanda Pharmaceuticals Inc. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-20 | Vanda Pharmaceuticals Inc. | $32 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-20 | Vanda Pharmaceuticals Inc. | $7 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $985 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-14 | E.R. Squibb & Sons, L.L.C. | $10 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-13 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-10 | Alkermes, Inc. | $2,290 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $843 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $326 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $51 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-08 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $275 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $138 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $59 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $52 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $35 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-25 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-09-24 | Teva Pharmaceuticals USA, Inc. | $4,493 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-24 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-24 | Teva Pharmaceuticals USA, Inc. | $148 | Travel and Lodging | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-24 | Teva Pharmaceuticals USA, Inc. | $146 | Travel and Lodging | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-24 | Teva Pharmaceuticals USA, Inc. | $56 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-24 | Axsome Therapeutics, Inc. | $32 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-24 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-24 | Axsome Therapeutics, Inc. | $5 | Food and Beverage | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Otsuka America Pharmaceutical, Inc. | $12 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-18 | Teva Pharmaceuticals USA, Inc. | $3,894 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-18 | Teva Pharmaceuticals USA, Inc. | $79 | Travel and Lodging | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-18 | Teva Pharmaceuticals USA, Inc. | $58 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-18 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-17 | Vanda Pharmaceuticals Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-17 | Vanda Pharmaceuticals Inc. | $1,402 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-17 | Vanda Pharmaceuticals Inc. | $120 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-17 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-09-16 | E.R. Squibb & Sons, L.L.C. | $10 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-15 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-12 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-12 | Axsome Therapeutics, Inc. | $7 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-11 | Vanda Pharmaceuticals Inc. | $2,730 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-11 | Vanda Pharmaceuticals Inc. | $409 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-11 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-10 | Vanda Pharmaceuticals Inc. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-10 | Vanda Pharmaceuticals Inc. | $1,680 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-10 | Vanda Pharmaceuticals Inc. | $410 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-10 | Vanda Pharmaceuticals Inc. | $88 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-10 | Vanda Pharmaceuticals Inc. | $17 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-10 | Otsuka America Pharmaceutical, Inc. | $7 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-09 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-05 | Vanda Pharmaceuticals Inc. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-05 | Vanda Pharmaceuticals Inc. | $496 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $97 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-05 | Vanda Pharmaceuticals Inc. | $95 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-05 | Vanda Pharmaceuticals Inc. | $91 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-04 | Vanda Pharmaceuticals Inc. | $2,730 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-04 | Vanda Pharmaceuticals Inc. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-04 | Vanda Pharmaceuticals Inc. | $475 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-04 | Vanda Pharmaceuticals Inc. | $187 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-04 | Vanda Pharmaceuticals Inc. | $34 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-04 | Vanda Pharmaceuticals Inc. | $21 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-04 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-29 | Otsuka America Pharmaceutical, Inc. | $2,548 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-29 | Teva Pharmaceuticals USA, Inc. | $560 | Consulting Fee | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-28 | Vanda Pharmaceuticals Inc. | $2,730 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-28 | Vanda Pharmaceuticals Inc. | $269 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-28 | Vanda Pharmaceuticals Inc. | $203 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-28 | Vanda Pharmaceuticals Inc. | $39 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-26 | Teva Pharmaceuticals USA, Inc. | $2,995 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-08-26 | Teva Pharmaceuticals USA, Inc. | $121 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-26 | Teva Pharmaceuticals USA, Inc. | $15 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-08-26 | Axsome Therapeutics, Inc. | $11 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-21 | Otsuka America Pharmaceutical, Inc. | $108 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-21 | E.R. Squibb & Sons, L.L.C. | $11 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-19 | Teva Pharmaceuticals USA, Inc. | $12 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $79 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $69 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $49 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $32 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $29 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $3 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $2 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $5,670 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Alkermes, Inc. | $960 | Consulting Fee | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $509 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $325 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $219 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $178 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $83 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $32 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $11 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $2 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-14 | E.R. Squibb & Sons, L.L.C. | $102 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-08 | E.R. Squibb & Sons, L.L.C. | $97 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-08 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-05 | Teva Pharmaceuticals USA, Inc. | $2,995 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-08-05 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-05 | Teva Pharmaceuticals USA, Inc. | $14 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-08-04 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-30 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-29 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-29 | Teva Pharmaceuticals USA, Inc. | $1 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 |
The latest 200 records of 2,312.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Canton, OH, county Stark County, OH, state Ohio; placed by its city name.
| Measure | Place (city or town) Canton, OH | County Stark County, OH | State Ohio |
|---|---|---|---|
| Population B01003 | 69,755 | 373,713 | 11,810,293 |
| Population, 2020 census P1 | 70,872 | 374,853 | 11,799,448 |
| Median age B01002 | 35.2 | 41.8 | 39.7 |
| Under 18 B01001 | 25.4% | 21.5% | 22.0% |
| 65 and over B01001 | 15.7% | 20.5% | 18.3% |
| Households B11001 | 29,302 | 155,955 | 4,863,191 |
| Foreign born B05002 | 2.5% | 2.2% | 5.2% |
| Median household income B19013 | $43,188 | $67,934 | $71,389 |
| Median family income B19113 | $53,992 | $86,156 | $92,749 |
| Per capita income B19301 | $24,690 | $36,762 | $40,552 |
| Poverty rate B17001 | 27.4% | 12.5% | 13.3% |
| Unemployment rate B23025 | 7.8% | 3.9% | 4.8% |
| Civilian labor force B23025 | 32,390 | 186,713 | 5,994,779 |
| Mean commute (minutes) B08013 | 19.1 | 21.7 | 23.4 |
| Bachelor's degree or higher B15003 | 16.4% | 25.9% | 31.5% |
| Housing units B25001 | 33,836 | 167,949 | 5,292,391 |
| Owner-occupied B25003 | 48.7% | 69.2% | 67.2% |
| Renters B25003 | 51.3% | 30.8% | 32.8% |
| Median home value B25077 | $97,800 | $186,400 | $214,800 |
| Median gross rent B25064 | $850 | $909 | $1,034 |
| White, not Hispanic B03002 | 59.0% | 83.8% | 75.8% |
| Black B03002 | 23.4% | 7.1% | 12.0% |
| Hispanic or Latino B03002 | 6.7% | 3.0% | 4.8% |
| Asian B03002 | 0.6% | 0.9% | 2.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Canton, OH.
Comments